Cargando…
Cross‐matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting
Allogeneic mesenchymal stromal cells (MSCs) have been used clinically for decades, without cross‐matching, on the assumption that they are immune‐privileged. In the equine model, we demonstrate innate and adaptive immune responses after repeated intra‐articular injection with major histocompatibilit...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046071/ https://www.ncbi.nlm.nih.gov/pubmed/33369287 http://dx.doi.org/10.1002/sctm.20-0435 |